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The mechanism by which TGF-b regulates renal inflammation
and fibrosis is largely unclear; however, it is well accepted
that its biological effects are mediated through Smad2 and
Smad3 phosphorylation. Following activation, these Smads
form heteromeric complex with Smad4 and translocate into
the nucleus to bind and regulate the expression of target
genes. Here we studied the roles of Smad4 to regulate TGF-b
signaling in a mouse model of unilateral ureteral obstruction
using conditional Smad4 knockout mice and in isolated
Smad4 mutant macrophages and fibroblasts. Disruption
of Smad4 significantly enhanced renal inflammation
as evidenced by a greater CD45þ leukocyte and F4/80þ
macrophage infiltration and upregulation of IL-1b, TNF-a,
MCP-1, and ICAM-1 in the obstructed kidney and in IL-1b-
stimulated macrophages. In contrast, deletion of Smad4
inhibited renal fibrosis and TGF-b1-induced collagen I
expression by fibroblasts. Further studies showed that
the loss of Smad4 repressed Smad7 transcription, leading
to a loss of functional protein. This, in turn, inhibited
IjBa expression but enhanced NF-jB activation, thereby
promoting renal inflammation. Interestingly, deletion
of Smad4 influenced Smad3-mediated promoter activities
and the binding of Smad3 to the COL1A2 promoter,
but not Smad3 phosphorylation and nuclear translocation,
thereby inhibiting the fibrotic response. Thus, Smad4
may be a key regulator for the diverse roles of TGF-b1
in inflammation and fibrogenesis by interacting with
Smad7 and Smad3 to influence their transcriptional
activities in renal inflammation and fibrosis.
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It has been known for long that transforming growth factor
(TGF)-b1 has a distinct role in regulating renal inflammation
and fibrosis.1–4 Although recent discovery of TGF-b/Smad
signaling has delineated the signaling mechanism of TGF-b1
in many physiopathological processes including develop-
ment, inflammation and immunity, tissue repair and
fibrogenesis, and cancer development, the mechanism by
which TGF-b diversely regulates the responses of renal
inflammation and fibrosis remains largely unclear. It is now
well accepted that after binding to its receptors, TGF-b1
exerts its biological effects through the activation of its
downstream mediators, Smad2 and Smad3, by phosphoryla-
tion. Further, the activated Smad2/3 form heteromeric
complex with Smad4, a common Smad, and translocate into
the nucleus to bind and regulate the expression of targeted
genes, which is negatively regulated by an inhibitory Smad,
namely Smad7.5 Emerging evidence has shown that Smad3
can transcriptionally bind the DNA sequences of the target
gene and has an important role in tissue repair and fibrosis
under various pathological conditions in the skin, liver, lung,
heart, and kidney.6–10 In contrast, Smad2 is protective in
renal fibrosis by counter-regulating Smad3 signaling.11
However, the functional role of Smad4 in the pathogenesis
of inflammation and fibrosis under pathological conditions
remains largely unknown. This may be attributed to the
unavailability of Smad4 knockout (KO) mice due to the early
embryonic lethality.12 Recent studies using conditional
Smad4 KO mice have demonstrated that specific deletion of
Smad4 from the heart impairs cardiogenesis or causes cardiac
hypotrophy and failure,13,14 whereas deletion of Smad4 from
the skin results in delayed wound healing and enhanced
inflammation-associated carcinogenesis.15 However, the
functional role of Smad4 in other diseased organs such as
kidney inflammation and fibrosis remains unexplored and,
more importantly, the underlying mechanisms of Smad4 in
regulating inflammation and fibrosis are not fully under-
stood. Considering the central position of Smad4 in TGF-b/
Smad signal transduction, the present study tested the
hypothesis that Smad4 may be a key regulator of TGF-b
signaling and may have an important regulatory role in renal
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inflammation and fibrosis. This hypothesis was examined
in vitro in fibroblasts and macrophages and in vivo in a
mouse model of unilateral ureteral obstructive (UUO) kidney
disease, in which Smad4 was conditionally deleted from the
kidney, as well as kidney fibroblasts and peritoneal macro-
phages using the Cres-Loxp technology. In addition, the
underlying mechanisms by which Smad4 regulates renal
inflammation and fibrosis were also determined.
RESULTS
Generation and characterization of conditional Smad4 KO
mice and cells
Conditional Smad4 KO mice (Smad4ff/KspCre) were gener-
ated by crossing the Smad4 flox/flox mice (Smad4ff) with the
kidney-specific promoter (Cadherin-16)-driven Cre mice
(KspCre) in which Smad4 was specifically deleted from
the kidney tubular epithelial cells. As shown in Figure 1a,
PCR revealed that transgenic expression of Cre recombinase
(235 bp) in the Smad4ff mouse induced a substantial deletion
of the floxed Smad4 gene (420 bp) by the Cre recombination
as defined by the deleted allele (500 bp). This result was
further confirmed by real-time PCR and western blot analysis
that B50% of Smad4 mRNA and protein was deleted from
kidneys of conditional Smad4 KO mice (Figure 1b and c).
Immunohistochemically, compared with the Smad4ff mice
in which Smad4 was highly expressed by all kidney cells,
Smad4ff/KspCre mice exhibited a marked deletion of Smad4
from most tubular epithelial cells, but not glomerular cells
(Figure 1d), because of the presence of active KspCre in
kidney tubular epithelial cells only. In vitro, compared with
the control Smad4ff cells, western blot analysis revealed
that transfection of adenovirus Cre substantially deleted the
Smad4 from peritoneal macrophage (Figure 1e) and kidney
fibroblast (Figure 1f) that were isolated from Smad4ff mice.
Deletion of Smad4 enhances renal inflammation in a mouse
model of the UUO kidney and in interleukin-1b-stimulated
macrophages
Histologically, there was no detectable abnormality of kidney
histology in conditional Smad4 KO mice, which was further
confirmed by no evidence of renal inflammation and fibrosis
detected by immunohistochemistry, real-time PCR, and
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Figure 1 |Characterization of conditional Smad4 knockout mice, peritoneal macrophages, and kidney fibroblasts. (a) PCR
demonstrates that the Cre recombination (235 bp) results in the Smad4-floxed gene (S4ff, 420 bp) being partly deleted from the
kidney (500 bp). (b, c) Real-time PCR and western blot analysis show a deletion of Smad4 mRNA and protein from the S4ff/KspCre
mouse kidney. (d) Immunohistochemistry detects that Smad4 is highly expressed by all kidney cell types (cytoplasm and nuclear staining)
in Smad4ff mice and is specifically deleted from most of the kidney tubular epithelial cells in S4ff/KspCre mice. (e, f) Western blot analysis
shows that Smad4ff macrophages and kidney fibroblasts cells infected with adenovirus Cre results in a substantial deletion of Smad4.
Data represent mean±s.e.m. for groups of six to eight mice or for four independent experiments in vitro. ###Po0.001 vs. Smad4ff mice.
Original magnifications  400 (d). GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Kidney International (2012) 81, 266–279 267
X-M Meng et al.: Role of Smad4 in renal inflammation and fibrosis o r ig ina l a r t i c l e
western blot analysis (Figures 2–4). However, the UUO
kidney with conditional deletion of Smad4 from tubular
epithelial cells significantly enhanced tubulointerstitial
CD45þ leukocyte and F4/80þ macrophage infiltration
when compared with the control Smad4ff mice (Figure 2).
Further studies by immunohistochemistry and real-time
PCR revealed that enhanced inflammatory cell infiltration in
the UUO kidney of Smad4 KO mice was associated with a
marked upregulation of proinflammatory cytokines such as
interleukin-1b and tumor necrosis factor (TNF)-a (Figure 3),
chemokine monocyte chemotactic protein-1 (MCP-1), and
adherent molecules (intercellular adhesion molecule-1;
Figure 4). These in vivo findings were also confirmed by
in vitro study in peritoneal macrophages. As shown in Figure 5a
and b, real-time PCR showed that the addition of interleukin-
1b was able to induce inflammatory response such as
interleukin-1b and intercellular adhesion molecule-1 mRNA
expression in a time- and dosage-dependent manner, peaking
at 1 h with an optimal dose of 10 ng/ml. Interestingly, disrup-
tion of Smad4 in macrophages not only enhanced interleukin-
1b-induced inflammatory responses but also largely blocked
the inhibitory effect of TGF-b1 on interleukin-1b-induced
upregulation of TNF-a, interleukin-1b, MCP-1, and inter-
cellular adhesion molecule-1 mRNA expression (Figure 5c–f),
revealing a necessary role for Smad4 in anti-inflammatory
property of TGF-b1.
Disrupted Smad4 impairs Smad7 transcriptional regulation
in nuclear factor jB activation in vivo and in vitro
We then examined mechanisms whereby deletion of Smad4
enhanced inflammatory responses in vivo and in vitro. We
have previously shown that Smad7 is a negative regulator of
TGF-b signaling in renal inflammation, which inactivates the
nuclear factor kB (NF-kB) pathway via induction of IkBa, an
inhibitor of NF-kB signaling.16 In the present study, we found
that enhanced renal inflammation in Smad4 KO mice was
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Figure 2 |Disruption of Smad4 from the kidney promotes inflammatory cell infiltration in a mouse model of unilateral ureteral
obstruction (UUO). (a) CD45þ leukocytes; (b) F4/80þ macrophages. Compared with the Smad4ff mouse, disruption of Smad4 from
S4ff/KspCre mice largely enhances tubulointerstitial inflammation by CD45þ leukocytes and F4/80þ macrophages. Data are expressed
as mean±s.e.m. for groups of six to eight mice. ***Po0.001 vs. normal; #Po0.05, ##Po0.01 vs. UUO kidneys of Smad4ff mice.
Original magnifications  400.
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associated with a loss of Smad7 in both mRNA and protein
levels (Figure 6a), which was accompanied by decreased IkBa
expression while increasing phospho-IkBa, thereby resulting in
activation of NF-kB/p65 as demonstrated by enhanced
phosphorylation and nuclear translocation of
NF-kB/p65 subunit in tubulointerstitium (Figure 6b and c).
Further in vitro studies in peritoneal macrophages found that
deletion of Smad4 resulted in abrogation of TGF-b1-induced
Smad7 mRNA and protein expression and promoter activity
(Figure 7a), which was associated with reduced IkBa expres-
sion and increased phosphorylation of both IkBa (P-IkBa) and
NF-kB/p65 (P-p65), and NF-kB response secreted alkaline
phosphatase (SEAP) promoter activities (Figure 7b and c).
Disruption of Smad4 inhibits renal fibrosis in a mouse model
of UUO and in vitro in TGF-b1-stimulated fibroblasts
As TGF-b/Smad signaling has been shown to have a key role
in renal fibrosis,1–4 we next investigated whether deletion of
Smad4 from the kidney and fibroblasts has an impact on
fibrogenesis. In contrast to renal inflammatory response,
TNF-α expression
(i) Immunohistochemistry (ii) Quantitation of IHC
(iii) Real-time PCR
(ii) Quantitation of IHC
(iii) Real-time PCR
S4ff
S4ff/KspCre
S4ff
S4ff/KspCre
S4ff
S4ff/KspCre
S4ff
S4ff/KspCre
##
***
***
##
***
##
**
*
***
27
18
9
0
0.0015
0.001
0.0005
0
60
40
20
0
%
Normal UUOR
at
io
 (T
NF
-α
/G
AP
DH
)
Normal UUO
Normal
0.002
0.001
0Ra
tio
 (IL
-1β
/G
AP
DH
)
UUO
Normal UUO
#
*
%
S4ff
N
or
m
a
l
UU
O
S4ff/KspCre
IL-1β expression
(i) Immunohistochemistry
S4ff
N
or
m
a
l
UU
O
S4ff/KspCre
Figure 3 |Disruption of Smad4 from the kidney enhances expression of proinflammatory cytokines (tumor necrosis factor (TNF)-a and
interleukin (IL)-1b) in the unilateral ureteral obstructive (UUO) kidney. (a) TNF-a expression; (b) IL-1b expression. (i) Immunohistochemistry
(IHC), (ii) quantitative data of IHC, (iii) real-time PCR for TNF-a or IL-1b mRNA expression. Compared with the Smad4ff mouse,
disruption of Smad4 from S4ff/KspCre mice largely enhances TNF-a and IL-1b mRNA and protein expression. Data are expressed as the
mean±s.e.m. for groups of six to eight mice. *Po0.05, **Po0.01, ***Po0.001 vs. normal; #Po0.05, ##Po0.01 vs. Smad4ff UUO mice.
Original magnifications  400. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Kidney International (2012) 81, 266–279 269
X-M Meng et al.: Role of Smad4 in renal inflammation and fibrosis o r ig ina l a r t i c l e
deletion of Smad4 from the kidney significantly reduced the
severity of tubulointerstitial fibrosis in the UUO kidney as
demonstrated by Masson’s trichrome staining (Figure 8).
Immunohistochemistry, real-time PCR, and western blot
analysis also revealed that collagen I expression within the
fibrotic kidney was also significantly inhibited in conditional
Smad4-deficient mice when compared with the Smad4-
floxed mice (Figure 9a–e). Similar results were also found in
TGF-b1-stimulated kidney fibroblasts in which disrupted
Smad4 significantly blocked TGF-b1-induced collagen I
mRNA and protein expression as determined by real-time
PCR and western blot analysis (Figure 9f and g).
Disrupted Smad4 impairs Smad3 transcriptional activities,
but does not alter Smad2/3 signaling in response to TGF-b1
in vitro
To explore the mechanism by which deletion of Smad4
inhibits renal fibrosis, we examined TGF-b1-induced Smad2/3
signaling in the UUO kidney and in kidney fibroblasts in
response to TGF-b1. Unexpectedly, disruption of Smad4 from
the kidney did not alter the activation level of Smad2/3, as
demonstrated by Smad3 phosphorylation and phospho-
Smad2/3 nuclear translocation by western blot analysis and
immunohistochemistry (Figure 10a and b). This was further
demonstrated in vitro that disrupted Smad4 from kidney
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Figure 4 |Disruption of Smad4 from the kidney enhances the expression of monocyte chemotactic protein-1 (MCP-1) and
intercellular adhesion molecule (ICAM)-1 in the unilateral ureteral obstructive (UUO) kidney. (a) MCP-1 expression; (b) ICAM-1
expression. (i) Immunohistochemistry, (ii) quantitative data of immunohistochemistry (IHC), (iii) real-time PCR for MCP-1 or ICAM-1 mRNA
expression. Compared with the Smad4ff mouse, disruption of Smad4 from S4ff/KspCre mice largely enhances MCP-1 and ICAM-1 mRNA and
protein expression. Data are expressed as the mean±s.e.m. for groups of six to eight mice. **Po0.01, ***Po0.001 vs. normal; #Po0.05,
##Po0.01, ###Po0.001 vs. Smad4ff UUO mice. Original magnifications  200. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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fibroblasts did not influence the levels of Smad3 phosphoryla-
tion in response to TGF-b1 (Figure 10c).
We then investigated whether deletion of Smad4 influ-
enced Smad3 transcriptional activities by examining the
Smad3/4 promoter activities and the binding of Smad3 to
COL1A2. Surprisingly, conditional deletion of Smad4 from
kidney fibroblasts did prevent TGF-b1-induced Smad3/4
promoter activities and the binding of Smad3 to COL1A2,
as determined by the chromatin immunoprecipitation assay
(Figure 11).
Next, we determined whether deletion of Smad4 has an
impact on Smad-independent signaling mechanisms by
examining the extracellular signal-regulated protein kinase
(ERK)1/2 phosphorylation. As shown in Figure 12, disrupted
Smad4 did not alter the increased phosphorylation levels
of ERK1/2 in the UUO kidney when compared with
Time-dependent response Dosage-dependent response
0.0012
a b
c d
e f
*
0.0007
*
** **
0.00035
0
0.0012
*
**
**
0.0006
0
0.0006
0
0.003 **
*
0.002
0.001
0
R
at
io
 (IC
AM
-1/
GA
PD
H)
0 h 1 h 3 h 6 h 12 h 24 h 0 5 10 20
0 5 10 200h 1 h 3 h 6 h 12 h 24 h
ICAM-1 mRNA ICAM-1 mRNA
IL-1β (10 ng/ml)
TNF-α mRNA IL-1β mRNA
MCP-1 mRNA
0.00070
0.00035
FF
***
**
**
##Cre
0
0 IL-1β
0.0004 FF
###
***
***
***
***
* *
*
***
###
††
†
†††
†
††
Cre
FF
Cre
FF0.00015
0.00010
0.00005
0
Cre
0.0002
0
0.0036
ICAM-1 mRNA
##
###
0.0024
0.0012
0
0 IL-1β TGFβ-1+
IL-1β
0 IL-1β TGF-β1+
IL-1β
0 IL-1β TGF-β1+
IL-1β
TGF-β1+
IL-1β
R
at
io
 (T
NF
-α
 
/G
AP
DH
)
R
at
io
 (IC
AM
-1/
GA
PD
H)
R
at
io
 (M
CP
-1/
GA
PD
H)
R
at
io
 (IL
-1β
/G
AP
DH
)
IL-1β (ng/ml,1h)
R
at
io
 (IL
-1β
/G
AP
DH
)
R
at
io
 (IL
-1β
/G
AP
DH
)
R
at
io
 (IC
AM
-1/
GA
PD
H)
IL-1β mRNA IL-1β mRNA
Figure 5 |Disruption of Smad4 prevents the anti-inflammatory effect of transforming growth factor (TGF)-b1 on interleukin-
1b-stimulated peritoneal macrophages in vitro. (a) A time-dependent response after interleukin-1b (IL-1b) stimulation (10 ng/ml).
(b) A dosage-dependent response (1 h after IL-1b stimulation). (c–f) The effect of TGF-b1 on interleukin-1b-induced mRNA expression
of tumor necrosis factor (TNF)-a (c), IL-1b (d), intercellular adhesion molecule (ICAM)-1 (e), and MCP-1 (f). Real-time PCR detects that
disruption of Smad4 from macrophages prevents the inhibitory effect of TGF-b1 on interleukin-1b-induced inflammatory response.
Macrophages were pretreated with TGF-b1 (2 ng/ml) for 12 h, followed by addition of interleukin-1b (10 ng/ml) for 1 h as described in
Materials and Methods. Data are expressed as mean±s.e.m. for four independent experiments. *Po0.05, **Po0.01, and ***Po0.001 vs.
normal (time or dose 0); ##Po0.01, ###Po0.001 vs. Smad4ff cells; wPo0.05, wwPo0.01, wwwPo0.001 vs. interleukin-1b treatment only. GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; MCP-1, monocyte chemotactic protein-1.
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Smad4-floxed mice, although a transient increase in
phospho-ERK1/2 was observed in conditional KO kidney
fibroblasts at 15min after addition of TGF-b1.
DISCUSSION
Emerging evidence shows that TGF-b1 functions by stimu-
lating its downstream mediators Smad2 and Smad3 to
exhibit its biological activities including inflammation and
fibrosis. Although Smad4 has been known as a common
Smad in the signal transduction pathway of the TGF-b
family, its functional role and mechanisms in TGF-b1-
regulated inflammatory and fibrosis responses remain largely
unclear. In the present study, we found that disruption of
Smad4 from the kidney resulted in largely enhanced renal
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shows that deletion of Smad4 inhibits IkBa expression but increases its phosphorylation (P-IkBa), resulting in enhanced NF-kB/p65
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inflammation including CD45þ leukocyte and F4/80þ
macrophage infiltration and upregulation of proinflamma-
tory cytokines, chemokines, and adhesion molecules in a
mouse model of UUO kidney. In contrast, deletion of Smad4
inhibited progressive renal fibrosis such as collagen matrix
expression. All these findings in vivo were also further evident
Smad7 expression and promoter activity by macrophages
IκBα expression and phosphorylation by macrophages
Activation of NF-κB/p65 by macrophages
IκBα
P-IκBα
GAPDH
(i) Western blot
(i) Western blot
(i) Western blot
FF
Smad7
GAPDH
0.5 FFCre #
R
at
io
(S
ma
d7
/G
AP
DH
)
0.25
0
IL-1β
TGF-β1
IL-1β TGF-β1+
IL-1β
–
– –
– +
– –
+ + +
+ +
IL-1β
TGF-β1
–
– –
– +
– –
+ + +
+ + Control IL-1β TGF-β1+
IL-1β
Control IL-1β TGF-β1+
IL-1β
IL-1β
TGF-β1
–
– –
– +
– –
+ + +
+ +
Cre FF Cre FF Cre
FF Cre FF Cre FF Cre
FF Cre
FF
P-p65
p65
GAPDH
Cre FF Cre FF Cre
1.5 FF ***
** †
#
(ii) p-p65
(iii) NF-κB promoter
Cre
FF
***
***
†††
###Cre
1
0.5
0
800
600
400
200
0
0.0050 FF
†††
###
***
Cre
(ii) Real-time PCR
(iii) Smad7 promoter
0.0025
0
0
6 ***
###
*
FF
Cre4
2
0
0 Control
(ii) IκBα
(iii) P-IκBα
2.4
*
##
***
*
#
1.8
1.2
0.6
0
1.2
0.6
0
R
at
io
(P
-Iκ
Bα
/G
AP
DH
)
R
at
io
(p-
p6
5/p
65
)
SE
AP
 a
ct
ivi
ty
R
at
io
(Iκ
Bα
/G
AP
DH
)
Smad7Lu
ci
fe
ra
se
 a
ct
iv
ity
Figure 7 |Disruption of Smad4 inhibits transforming growth factor (TGF)-b1-induced Smad7 expression and promoter activity,
but promotes loss of IjBa while enhancing interleukin-1b-stimulated IjBa degradation and nuclear factor jB (NF-jB) activation
in macrophages in vitro. (a) Real-time PCR, western blot analysis, and promoter assay detect that disrupted Smad4 enhances a loss
of Smad7 mRNA and protein expression and promoter activity in response to TGF-b1 (2 ng/ml) in peritoneal macrophages. (b, c) Western
blot analysis shows that deletion of Smad4 reduces IkBa expression and results in a loss of inhibitory effect of TGF-b1 on interleukin-1b
(10 ng/ml)-stimulated IkBa degradation (P-IkBa) and NF-kB/p65 phosphorylation (P-p65) by macrophages. Furthermore, the NF-kB SEAP
promoter assay also shows that disrupted Smad4 prevents the inhibitory effect of TGF-b1 on interleukin-1b-induced NF-kB SEAP promoter
activities. Data are expressed as mean±s.e.m. for three to four independent experiments. *Po0.05, **Po0.01, ***Po0.001 vs. control;
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in vitro that deletion of Smad4 from macrophages or
fibroblasts resulted in a loss of suppressive effect of TGF-b1
on interleukin-1b-stimulated inflammation, while inhibiting
TGF-b1-mediated renal fibrosis. Taken together, results from
the present study demonstrated that Smad4 not only served
as a common Smad in signal transduction of the TGF-b
family, but also had an essential role in anti-inflammation
and fibrogenesis under pathological conditions.
A new and most significant finding in this study was that
impaired Smad7 transcriptional regulation in inhibition of
NF-kB signaling was a mechanism by which disrupted Smad4
enhanced renal inflammation in the UUO kidney and
interleukin-1b-stimulated macrophages. It has been shown
that Smad7 transcription is regulated by TGF-b1 through
direct binding of Smad3 and Smad4 to the Smad7
promoter.17 Studies in Smad2 and Smad3 KO mouse
embryonic fibroblasts and Smad4-null MD-MBA-468 cell
line confirm that Smad3 and Smad4, instead of Smad2, are
necessary for the induction of the Smad7 promoter reporter
gene in response to TGF-b.18 Thus, disrupted Smad4 resulted
in a loss of Smad7 expression transcriptionally and impaired
Smad7 promoter activities functionally, as found in the
present study. Consistent with the previous findings that
Smad7 is capable of inducing IkBa expression, an inhibitor
of NF-kB, thereby inhibiting NF-kB-driven renal inflamma-
tion,16,19 the present findings that disruption of Smad4
promoted NF-kB-dependent inflammation in vivo and
in vitro by downregulating IkBa expression in a Smad7-
dependent manner added new evidence that Smad4 may be
a key regulator in TGF-b/Smad7-mediated inhibition of
NF-kB-driven inflammation. This novel finding was further
supported by the ability of disrupted Smad4 to prevent the
inhibitory effect of TGF-b1 on interleukin-1b-induced
inflammatory response in macrophages.
Interestingly, in contrast to enhanced renal inflammation,
disruption of Smad4 suppressed renal fibrosis in the UUO
kidney and TGF-b1-stimulated fibroblasts. This observation
was consistent with a previous study that deletion of Smad4
from mesangial cells inhibited extracellular matrix deposition
induced by TGF-b1.20 More importantly, we found that
inhibition of renal fibrosis by deleting Smad4 was associated
with impaired Smad3 transcriptional activities, instead of
Smad2/3 activation. It is now well accepted that TGF-b1 is a
key mediator of fibrosis by causing phosphorylation of
Smad2 and Smad3, which forms a complex with Smad4 and
then translocates to nuclei to bind the target genes.21,22
However, the present study found that disrupted Smad4 did
not alter phosphorylation levels of Smad2/3 nor phospho-
Smad2/3 nuclear translocation in the UUO kidney and TGF-
b1-stimulated fibroblasts, suggesting that Smad4 may not be
required for either TGF-b1-induced phosphorylation of
Smad2/3 or phospho-Smad2/3 nuclear translocation. This
finding is consistent with a previous study in Smad4-null
cancer cell lines in which deletion of Smad4 does not prevent
nuclear translocation of Smad2 and Smad3.23 In contrast, we
found that inhibition of renal fibrosis in conditional Smad4
KO mice and fibroblasts was associated with impaired
transcriptional activity of Smad3 as evidenced by blocking
TGF-b-induced Smad3/4 promoter activity and the binding
of Smad3 to the COL1A2 promoter. It is known that Smad3-
binding sequences are located in the promoter regions of
COL1A2, COL2A1, COL3A1, COL5A1, COL6A1, and
COL6A3;24–26 thus, deletion of Smad4 may influence the
binding activity of Smad3 to the collagen promoter, thereby
inhibiting TGF-b-induced fibrotic response.
In the present study, we also found that deletion of Smad4
had minimal effect on activation of ERK1/2 because
disrupted Smad4 from the kidney did not alter the
phosphorylation levels of ERK1/2 in the UUO kidney,
although significant but transient phosphorylation levels of
ERK1/2 were induced in conditional Smad4 KO kidney
fibroblasts in response to TGF-b1 in vitro. Indeed, TGF-b1 is
capable of activating the ERK pathway to mediate renal
fibrosis.27,28 However, results from the present study implied
that although TGF-b1 functions by stimulating both
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Smad-dependent and -independent pathways to exert its
biological activities,22 the Smad-dependent mechanism may
be a major pathway leading to renal fibrosis, as disrupted
Smad4 significantly attenuated severe tubulointerstitial
fibrosis in a mouse model of obstructive nephropathy.
In conclusion, the present study demonstrates that Smad4
may be a key regulator for diverse roles of TGF-b1 in anti-
inflammation and fibrogenesis. Smad4 may interact with
Smad7 and Smad3 to influence their functional activities
transcriptionally in renal inflammation and fibrosis.
MATERIALS AND METHODS
Generation of conditional Smad4 KO mice
Smad4 flox/flox mouse (C57B/L6) was crossed with KspCre (C57B/
L6) mouse to specifically delete Smad4 from the kidney tubular
epithelial cells. The generation and characterization of the Smad4
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flox mouse and KspCre transgenic mouse are described pre-
viously.29,30 PCR, quantitative real-time PCR, western blotting
analysis, and immunohistochemistry were used to identify the
specific deletion of Smad4 from the kidney as shown in Figure 1.
Mouse model of unilateral ureteral obstruction
A mouse model of UUO nephropathy was induced in genetically
identical littermates of Smad4ff and S4ff/KspCre mice by the left
ureteral ligation as previously described.31 Groups of six to eight
mice were used. Kidney tissue samples were harvested for
immunohistochemistry, western blot analysis, and real-time reverse
transcription-PCR as previously described.32 The experimental
procedures were approved by the Animal Ethics Committee of
Chinese University of Hong Kong.
Generation of conditional Smad4 KO macrophages and
fibroblasts
Peritoneal macrophage was obtained from the Smad4ff mice by 1 h
adhesion on the culture plastic disk and determined by immuno-
histochemistry with more than 90% of F4/80þ . Smad4 FF kidney
fibroblast was isolated and characterized as previously described.33
The isolated cells were cultured with RPMI 1640 containing 15%
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fetal bovine serum for three passages, and Smad4 was conditionally
deleted by infecting cells with Cre-expressing adenovirus (MOI of
50) as previously described.34 Cells infected with adenovirus b-gal
were used as a control. Smad4 deletion from the cells was
determined by western blot analysis using anti-Smad4 antibody.
The characterized conditional Smad4 KO or Smad4ff macro-
phages were stimulated with recombinant human interleukin-1b
(R&D Systems, Minneapolis, MN) at concentrations of 0, 5, 10, and
20 ng/ml for periods of 0, 1, 3, 6, 12, and 24 h for the detection of
inflammatory response. To determine a role of Smad4 in anti-
inflammatory effect of TGF-b1, macrophages were pretreated with
recombinant human TGF-b1 (R&D Systems) for 12 h, followed by
the addition of an optimal dose of interleukin-1b (10 ng/ml).
Similarly, the role of Smad4 in regulation of TGF-b1-induced
fibrosis response was determined in conditional Smad4 KO or
Smad4ff kidney fibroblasts by addition of TGF-b1(2 ng/ml) for
periods of 0, 3, 12, and 24 h, respectively. Both inflammatory and
fibrosis responses were determined at the mRNA level by real-time
PCR and at the protein levels by western blot analysis following the
protocol as previously described.16,32,34,35 At least three independent
experiments were performed.
RNA extraction and real-time PCR examination
Total RNAwas extracted from kidney tissues and cultured cells using
the RNeasy Isolation Kit (Qiagen, Valencia, CA) according to the
manufacturer’s instructions. Real-time PCR was performed using
the Bio-Rad iQ SYBR Green supermix with Opticon2 (Bio-Rad,
Hercules, CA) as previously described.32 The primers used in this
study, including mouse collagen I, MCP-1, interleukin-1b, TNF-a,
and glyceraldehyde 3-phosphate dehydrogenase, were described
previously.16,32 Other primers include the following: Smad4
forward: 50-AGCCGTCCTTACCCACTGAA-30, reverse: 50-GGTGG
TAGTGCTGTTATGATGGT-30. The ratio for the mRNA of interest
was normalized with glyceraldehyde 3-phosphate dehydrogenase
and expressed as the mean±standard errors of the mean (s.e.m.).
Masson’s trichrome staining and immunohistochemistry
To evaluate the histological damage, Masson’s trichrome staining
was performed with the ‘Trichrome stain kit’ (Scy Tek Laboratoris,
West Logan, UT) according to the manufacturer’s instruction.
In addition, immunohistochemistry was performed in paraffin
sections to examine renal inflammation and fibrosis using a micro-
wave-based antigen retrieval technique.35 The antibodies used in this
study included MCP-1 (eBioscience, San Diego, CA), TNF-a,
interleukin-1b, ICAM-1, F4/80, CD45, phospho-Smad2/3 (Santa
Cruz Biotechnology, Santa Cruz, CA), collagen I (Southern Biotech,
Birmingham, AL), and Phospho-p65NF-kB (Cell Signaling Technol-
ogy, Danvers, MA). Sections were counterstained with hematoxylin
after immunostaining. Positive signals were quantitatively analyzed
using the quantitative Image Analysis System (AxioVision 4, Carl
Zeiss, Jena, Germany) as described previously.32,35
Western blot analysis
Proteins from kidney tissues and cultured cells were extracted with
RIPA lysis buffer, and western blot analysis was performed as
described previously.16 After blocking nonspecific binding with 5%
BSA (1 h, reverse transcription), membranes were then incubated
with the primary antibody against Smad4, total Smad3, collagen I
(Southern Biotech), phospho-Smad3, Phospho-p65NF-kB, p65NF-
kB, phospho-IkBa, IkBa, total ERK1/2 (Cell Signaling Technology),
Smad7, P-ERK1/2 (Santa Cruz Biotechnology), glyceraldehyde 3-
phosphate dehydrogenase (Chemicon, Temecula, CA) overnight at
4 1C, followed by treatment with IRDye 800-conjugated secondary
antibody (Rockland immunochemicals, Gilbertsville, PA). Signals
were captured using the LiCor/Odyssey infrared image system (LI-
COR Biosciences, Lincoln, NE). Signal intensities of each western
blot band were quantified and analyzed by using the Image J
software (NIH, Bethesda, MD, USA).
Promoter assays
Kidney fibroblasts were transiently transfected with p(CAGA)12-Luc
plasmid (Smad3/4-responsive promoter) and macrophages were
transfected with Smad7 promoter reporter or the specific NF-kB-
responsive promoter 241RMI-SEAP (secreted alkaline phosphatase)
plasmid using jetPEI (Polyplus-transfection, New York, NY), following
the protocol described previously.17,36 PGL3 basic plasmid was
co-transfected into the cells as control and renilla plasmid for
transfection efficiency. The Smad3/4 and Smad7 luciferase activities
were analyzed by the Dual-Luciferase Reporter Assay System according
to the manufacturer’s instructions (Promega, San Luis Obispo, CA)
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and were reported as the firefly luciferase activity normalized to renilla
luciferase activity, whereas the NF-kB SEAP activities were detected by
the SEAP reporter gene assay kit (Roche, Indianapolis, IN) and were
reported as the SEAP activity normalized to protein concentration
measured with the Lowry protein assay (Bio-Rad). Three independent
experiments were performed throughout the study.
Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation was performed with the transcrip-
tion factor chromatin immunoprecipitation kit according to the
manufacturer’s instructions and as previously described.11 Precipi-
tated DNAs were detected by PCR using specific primers to detect
the binding of Smad3 to COL1A2: forward: 50-AGGCAGGTCTGG
GCTTTATT-30. reverse: 50-CGTATCCACAAAGCTGAGCA-30.
Statistical analysis
Data obtained from this study are expressed as mean±s.e.m.
and were analyzed using one-way analysis of variance, followed
by Newman–Keuls post hoc test (Prism 5.0 GraphPad Software,
San Diego, CA).
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